William Blair Initiates Coverage On Rhythm Pharmaceuticals with Outperform Rating
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiation
William Blair analyst Alethia Young initiates coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Outperform rating.
William Blair analyst Alethia Young initiates coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Outperform rating.